Katharina Madlener

Monitoring of r-Hirudin Anticoagulation during Cardiopulmonary Bypass – Assessment of the Whole Blood Ecarin Clotting Time

Bernd Pötzsch, Katharina Madlener, Christoph Seelig et al. · Thrombosis and Haemostasis · 1997 · 187 citations

MONITORING OF RECOMBINANT HIRUDIN: ASSESSMENT OF A PLASMA-BASED ECARIN CLOTTING TIME ASSAY

Bernd Pötzsch, Simone Hund, Katharina Madlener et al. · Thrombosis Research · 1997 · 114 citations

Thrombosis, Medicine, Bioanalysis +10

Anemia as a risk factor for cerebral venous thrombosis? An old hypothesis revisited

Erwin Stolz, José M. Valdueza, Mathias Grebe et al. · Journal of Neurology · 2007 · 90 citations

Cerebral Venous Thrombosis, Neurovascular Disease, Anemia +17

Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia

Marc Schindewolf, Julia Steindl, Jan Beyer‐Westendorf et al. · Journal of the American College of Cardiology · 2017 · 78 citations

Thrombopoiesis, Thrombosis, Fondaparinux Off-label +9

Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT) – findings from the GerHIT multi-centre registry study

Marc Schindewolf, Julia Steindl, Jan Beyer‐Westendorf et al. · Thrombosis Research · 2014 · 59 citations

Thrombosis, Blood Platelet, Hematology +6